As I have documented in this blog numerous times, I am paying out-of-pocket for Abbott’s Libre Freestyle 3 Continuous glucose Monitor. It offers enough value to my life to make it well worth the expense. Turns out my brother-in-law Jerry is in the same boat.
Up to now, for about nine months, I have been paying $192.00 per month for two Libre 3s. I purchase them from HealthWarehouse.com out of Florence, KY under prescription from my GP. On 7/20/2023 my most recent shipment arrived with a billing of $154.12, a $37.88 reduction in price. No reason was provided but let’s surmise.
Why would Abbott drop the price of the Libre 3? They are already less expensive than the Dexcom G7 and also last longer. Dexcom is their nearest competitor I posit. I postulate further that their separate reading device which is required to gather Medicare coverage is about to be approved. They are using penetration pricing to be very attractive to insurance companies for coverage and thus increase the numbers game down their experience curve.
Have any readers of this blog experienced a drop in their Libre 3 prices?
Leave a Reply